Your search returned the following 5 documents:

5. Deep sequencing reveals mutagenic effects of ribavirin during monotherapy of HCV genotype 1-infected patients
   J. Dietz, Sven-Eric Schelhorn, D. Fitting, U. Mihm, S. Susser, M.-W. Welker, C. Füller, M. Däumer, G. Teuber, H. Wedemeyer, T. Berg, Thomas Lengauer, Stefan Z., E. Herrmann, and C. Sarrazin
   Journal of Virology 87 (11): 6172-6181, 2013
   
4. Comparison of Envelope 2 CD81 binding regions in PBMC-derived versus serum-derived hepatitis C virus isolates: higher conservation of CD81 region 2 in PBMC isolates
   M.-W. Welker, Christoph Welsch, D. Ochs, W. P. Hofmann, E. Herrmann, A. Piiper, R. W. Hartmann, S. Zeuzem, C. Sarrazin, and Bernd Kronenberger
   Journal of Viral Hepatitis 18 (3): 181-192, 2011
   
3. Structural and functional comparison of the non-structural protein 4B of flaviviridae
   Christoph Welsch, Mario Albrecht, Jochen Maydt, E. Herrmann, M.W. Welker, C. Sarrazin, A. Scheidig, Thomas Lengauer, and S. Zeuzem
   Journal of Molecular Graphics and Modeling 26 (2): 546-557, 2007
   
2. Association of HCV-related mixed cryoglobulinemia with specific mutational patterns of the HCV E2 protein and CD81 expression on peripheral B lymphocytes
   W.P. Hofmann, E. Herrmann, B. Kronenberger, Christian Merkwirth, Christoph Welsch, Thomas Lengauer, S. Zeuzem, and C. Sarrazin
   Blood 104 (4): 1228-1229, 2004
   
1. Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection.
   Thomas Lengauer, Mario Albrecht, C. Sarrazin, U. Mihm, E. Herrmann, Christoph Welsch, U. Sarrazin, S. Traver, and S. Zeuzem
   Journal of Infectious Diseases 192 (10): 1710-1719, 2005